About the Authors
- Sara Landgren
-
Affiliation Department of Pharmacology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Jeffrey A. Simms
-
Affiliation Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America
- Dag S. Thelle
-
Affiliation Department of Biostatistics, Institute of Basic Medical Science, University of Oslo, Oslo, Norway
- Elisabeth Strandhagen
-
Affiliation School of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Selena E. Bartlett
-
Affiliation Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America
- Jörgen A. Engel
-
Affiliation Department of Pharmacology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Elisabet Jerlhag
-
* E-mail: elisabet.jerlhag@pharm.gu.se
Affiliation Department of Pharmacology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Competing Interests
Authors Elisabet Jerlhag and Jörgen A. Engel are owners in a company holding a patent regarding treatment of chemical addiction by administering a compound which blocks ghrelin action. This does not alter the authors' adherence to the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SL JAE EJ. Performed the experiments: SL JAS EJ. Analyzed the data: SL JAS EJ. Contributed reagents/materials/analysis tools: SL JAS DST ES SEB JAE EJ. Wrote the paper: SL JAS DST ES SEB JAE EJ.